Cargando…
Corrigendum: Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
Autores principales: | Wang, Fangfang, Mayca Pozo, Franklin, Tian, Danmei, Geng, Xinran, Yao, Xinsheng, Zhang, Youwei, Tang, Jinshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378846/ https://www.ncbi.nlm.nih.gov/pubmed/32765281 http://dx.doi.org/10.3389/fphar.2020.01088 |
Ejemplares similares
-
Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction
por: Wang, Fangfang, et al.
Publicado: (2020) -
Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR
por: Wang, Fangfang, et al.
Publicado: (2022) -
MYO10 regulates genome stability and cancer inflammation through
mediating mitosis
por: Pozo, Franklin Mayca, et al.
Publicado: (2023) -
53BP1 regulates heterochromatin through liquid phase separation
por: Zhang, Lei, et al.
Publicado: (2022) -
Author Correction: 53BP1 regulates heterochromatin through liquid phase separation
por: Zhang, Lei, et al.
Publicado: (2022)